Fatty Liver Response of Cardio-metabolic Risk Factors to Laser Acupuncture Versus Cupping

Fatty Liver Clinical Trial

Official title:

Non-alcoholic Fatty Liver Response of Cardio-metabolic Risk Factors to Laser Acupuncture Versus Cupping-with-scarification

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT04971434
• Other study ID #: P.T.REC/012/003251
• Status: Recruiting
• Phase: N/A
• Start date: July 11, 2021
• Est. completion date: December 1, 2021

Study information

• Verified date: July 2021
• Source: Cairo University
• Contact: Ali Ismail, lecturer
• Phone: 02 01005154209
• Email: allooka2012[@]gmail.com
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Every-two-week applied cupping (with scarification) session within one month on back of upper thorax is not compared previously regarding its effect on cardio-metabolic risk factors to the daily application of laser on acupoints (for month, except Fridays) in fatty liver patients. This trial will compare the two procedure effects on cardio-metabolic risk factors in fatty liver.

Description:

In fatty liver patients,every-two-week applied cupping (with scarification) session within one month on back of upper thorax for 30 patients will be compared regarding its effect on cardio-metabolic risk factors to the daily application of laser on acupoints (for month, except Fridays) of other 30 patients.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 60
• Est. completion date: December 1, 2021
• Est. primary completion date: December 1, 2021
• Accepts healthy volunteers: No
• Gender: All
• Age group: 35 Years to 55 Years

Eligibility

Inclusion Criteria:

• Diagnosed Fatty liver patients by ultrasonography

• Class I obese patients

Exclusion Criteria:

• Cardiovascular and respiratory disorders/diseases.

• Autoimmune disorders/diseases.

• Pregnancy

• Other liver disorders/diseases.

Related Conditions & MeSH terms

• Fatty Liver

Intervention

Device:
• laser stimulation for acupoints
In fatty liver patients (30 patients), a daily application of 4-minute laser (for one month, except Fridays) on acupoint number 25,40,36 of stomach meridian, acupoint number 3 of liver meridian, acupoint number 6 of spleen meridian,acupoint number 9,12,4 of conception vessel meridian, acupoint number 14 of governor vessel meridian, acupoint number 4, 11 of large intestine meridian, acupoint number 34 of gall bladder meridian

Other:
• cupping with scarification
In fatty liver patients (30 patients),every-two-week applied cupping (with scarification) session within one month on back of upper thorax

Locations

Country	Name	City	State
Egypt	Faculty of Physical Therapy Cairo University	Giza	Dokki

Sponsors (1)

Lead Sponsor	Collaborator
Cairo University

Country where clinical trial is conducted

Egypt, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	high-density lipoprotein	serum lipid	It will be measured after 4 weeks of treatment
Primary	low-density lipoprotein	serum lipid	It will be measured after 4 weeks of treatment
Primary	cholesterol	serum lipid	It will be measured after 4 weeks of treatment
Primary	triglyceride	serum lipid	It will be measured after 4 weeks of treatment
Secondary	c reactive protein	it will be measured in plasma	It will be measured after 4 weeks of treatment
Secondary	blood glucose	fasting gluocse	It will be measured after 4 weeks of treatment
Secondary	blood pressure	it will be measure with manual manometer	It will be measured after 4 weeks of treatment
Secondary	rate of pulse	it will be measured at radial artery	It will be measured after 4 weeks of treatment